Searchable abstracts of presentations at key conferences in endocrinology

ea0027s16 | Symposium 1–Update on Adrenal Disorders | BSPED2011

Familial glucocorticoid deficiency: an update

Clark Adrian J L , Hughes Claire , Meimaridou Eirini , Metherell Lou

Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterized by resistance to the action of ACTH leading to glucocorticoid deficiency with preserved mineralocorticoid and gonadal function. In 1993 we identified mutations in the ACTH receptor (melanocortin 2 receptor; MC2R), although these only explained around 25% of cases. More recently a traditional homozygosity mapping approach identified mutations in a novel gene which we named melan...

ea0051oc5.3 | Oral Communications 5 | BSPED2017

Novel evidence implies that ALADIN, the triple A syndrome gene product is involved in mitochondrial physiology

Da Costa Alexandra Rodrigues , Meimaridou Eirini , Prasad Rathi , Metherell Louise A. , Chapple J. Paul , Storr Helen L.

Triple A syndrome (AAAS), a rare and debilitating autosomal recessive disorder. It is characterised by adrenal failure, alacrima and achalasia; ~70% patients develop a neurodegeneration. The AAAS gene encodes ALADIN, a nuclear pore complex (NPC) protein necessary for the selective nuclear import of DNA protective molecules and is important for cellular redox homeostasis. ALADIN’s role is not fully characterised: its discovery at the centrosome and the endoplasmic...

ea0041oc9.3 | Endocrine Tumours | ECE2016

Stressed to death – antioxidant pathway targeting as a novel therapeutic approach in adrenocortical carcinoma

Chortis Vasileios , Taylor Angela E , Doig Craig L , Meimaridou Eirini , Metherell Louise A , Arlt Wiebke , Foster Paul A

Context: Nicotinamide nucleotide transhydrogenase (NNT) is a NADPH-generating mitochondrial proton pump with a central role in mitochondrial antioxidant pathways. Recent studies revealed inactivating NNT mutations in patients with familial glucocorticoid deficiency, indicating a selective susceptibility of the adrenal cortex to NNT deficiency and oxidative stress. Here we explored the potential value of NNT as a therapeutic target in adrenocortical cancer.<p class="abstext...

ea0038oc1.3 | Early Career Oral Communications | SFEBES2015

RNA-sequencing of mouse adrenals reveals the pathways perturbed by loss of nicotinamide nucleotide transhydrogenase

Meimaridou Eirini , Goldsworthy Michelle , Chortis Vasileios , Foster Paul , Arlt Wiebke , Cox Roger , Metherell Lou

Nicotinamide nucleotide transhydrogenase (NNT) is a highly conserved inner mitochondrial membrane protein, which supplies high concentrations of NADPH for detoxification of reactive oxygen species (ROS) by glutathione and thioredoxin pathways. In humans, loss-of-function mutations in NNT cause familial glucocorticoid deficiency, a potentially fatal, adrenal specific disorder characterized by increased levels of ACTH and low levels of cortisol. Nnt−...

ea0038p145 | Neoplasia, cancer and late effects | SFEBES2015

Nicotinamide nucleotide transhydrogenase (NNT) as a novel molecular target in adrenocortical carcinoma – impact of NNT knockdown on adrenocortical cell proliferation, redox balance and steroidogenesis

Chortis Vasileios , Taylor Angela , Doig Craig , Meimaridou Eirini , Metherell Lou , Arlt Wiebke , Foster Paul

Nicotinamide nucleotide transhydrogenase (NNT) is a NADPH-generating mitochondrial proton pump with a central role in mitochondrial antioxidant pathways. Recent studies revealed inactivating NNT mutations in patients with familial glucocorticoid deficiency, indicating a selective susceptibility of the adrenal cortex to NNT deficiency and oxidative stress. Here we explored the potential value of NNT as a therapeutic target in adrenocortical cancer. We delineated the distinct ef...

ea0035p38 | Adrenal cortex | ECE2014

Mitochondrial thiol systems are important players in antioxidant defence for the human adrenal cortex

Meimaridou Eirini , Prasad Rathi , Kowalczyk Julia , Clark Adrian , Storr Helen , Metherell Lou

Familial glucocorticoid deficiency (FGD) results from the inability of the adrenal cortex to produce cortisol in response to ACTH stimulation and can be fatal if unrecognised. The disease manifests clinically with increased ACTH and reduced cortisol levels. Our group has recently demonstrated that oxidative stress is implicated in the pathogenesis of this disorder.We previously identified mutations in nicotinamide nucleotide transhydrogenase (NNT) in pat...

ea0030p1 | (1) | BSPED2012

A homozygous glutathione peroxidase 1 mutation, p. Arg130-Leu133del, in a patient with familial glucocorticoid deficiency

Kowalczyk Julia , Meimaridou Eirini , Guasti Leo , Clark Adrian J L , Metherell Lou A

Familial glucocorticoid deficiency is an autosomal recessive disorder characterised by resistance to ACTH of the adrenal cortex, leading to isolated glucocorticoid deficiency and life-threatening hypoglycaemia. Half of all cases are caused by mutations in MC2R, MRAP, MCM4 or STAR. Recent work in our group has identified defects in nicotinamide nucleotide transhydrogenase (NNT) to be causal in a further 10% of cases. NNT generates the high con...

ea0028oc1.6 | Young Endocrinologists prize session | SFEBES2012

A homozygous glutathione peroxidase 1 mutation, p. Arg130-Leu133del, in a patient with Familial Glucocorticoid Deficiency

Kowalczyk Julia , Meimaridou Eirini , Guasti Leonardo , Nurnberg Peter , Touraine Philippe , King Peter , Metherell Lou

Background: Familial Glucocorticoid Deficiency is an autosomal recessive disorder characterised by ACTH resistance of the adrenal cortex, leading to isolated glucocorticoid deficiency. Causative genes include MC2R, its accessory protein MRAP and StAR which account for 50% of cases. Recently nicotinamide nucleotide transhydrogenase (NNT) has been associated with a further 10% of cases. NNT generates the high concentrations of NADPH in mitochondria necessary for detoxification o...

ea0027oc1.6 | Oral Communications 1 | BSPED2011

Twenty novel mutations in nicotinamide nucleotide transhydrogenase (NNT) causing FGD

Metherell Lou , Meimaridou Eirini , Kowalczyk Julia , Guasti Leo , Hughes Claire , Mann Nicholas , Banerjee Ritwik , King Peter , Clark Adrian

Familial glucocorticoid deficiency (FGD;OMIM 202200) results from the inability of the adrenal cortex to produce cortisol in response to ACTH stimulation. Half of all cases are caused by mutations in MC2R, MRAP or STAR. SNP array genotyping of FGD patients of unknown aetiology mapped a disease locus to chromosome 5p13-q12. Targeted exome sequencing of 5p13-q12 in one patient identified a homozygous mutation, p.Ala533Val, in nicotinamide nucleotide transhyd...

ea0027oc2.3 | Oral Communications 2 (Quick Fire) | BSPED2011

MCM4 mutation causes a novel DNA replication disorder associated with short stature and adrenal failure

Hughes Claire , Guasti Leonardo , Meimaridou Eirini , Chaung Chen-Hua , Schimenti John , King Peter , Costigan Colm , Clark Adrian , Metherell Louise

Introduction: A unique variant of familial glucocorticoid deficiency (FGD) exists in the Irish travelling community, a genetically isolated population with high levels of consanguinity. Affected children develop hypocortisolaemia and raised ACTH but retain normal renin and aldosterone levels. Children also have short stature, evidence of increased chromosomal breakage and natural killer cell deficiency.Methods: We sought areas of homozygosity common to a...